Boston Scientific (BSX) FCF Margin (2009 - 2026)

Boston Scientific has disclosed FCF Margin across 18 years of filings, most recently posting 23.5% for Q2 2026.

• In Q2 2026, FCF Margin rose 119.0% year-over-year to 23.5%; the TTM figure through Jun 2026 stood at 17.27% (down 158.0% YoY), while the FY2025 annual figure was 18.22%, up 243.0% from the prior year.
• FCF Margin came in at 23.5% for Q2 2026 at Boston Scientific, up from 3.29% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 25.85% in Q4 2024 to a low of 5.92% in Q1 2022.
• Average FCF Margin over 5 years is 13.23%, with a median of 15.19% recorded in 2023.
• The largest YoY upside for FCF Margin was 1157 bps in 2022 against a maximum downside of 1351 bps in 2022.
• Over 5 years, FCF Margin stood at 18.35% in 2022, then grew by 1 bps to 18.52% in 2023, then jumped by 40 bps to 25.85% in 2024, then dropped by 26 bps to 19.16% in 2025, then increased by 23 bps to 23.5% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 23.5% in Q2 2026, 3.29% in Q1 2026, and 19.16% in Q4 2025.